BioSpace News Archive

BioMidwest

CT Uncovers Bone Disease in Tyrannosaurus Rex Jaw

Researchers in Germany identified bone disease in the fossilized jaw of a Tyrannosaurus rex using a CT-based, nondestructive imaging approach, according to a study being presented at the annual meeting of the Radiological Society of North America.

December 1, 2021
·
3 min read
Genetown

Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating Age-related Diseases

Apollo Health Ventures announces the final closing of its second venture fund to build a portfolio of data-driven biotechnology and healthtech ventures aimed at extending human healthspan.

December 1, 2021
·
4 min read
Ortoma obtains JP certification for hip implant planning module

Ortoma has obtained certification in Japan for its module OTS Hip Plan for pre-operative planning of hip replacement surgery.

December 1, 2021
·
1 min read
Renal Anemia Treatment Market: Rising cases of chronic kidney disease worldwide to drive the market

Renal anemia is a condition that develops from lower count of healthy red blood cells in the body. Generally in case of anemia, the red blood cells in the body carry less oxygen to organs and tissues.

December 1, 2021
·
5 min read
Prostate Stents Market: Increase in cases of benign prostatic hyperplasia to drive the market

Prostate stents are medical devices used to keep open the space surrounding prostatic urethra and bladder neck in order to allow smooth urine flow in case of urine incontinence.

December 1, 2021
·
4 min read
Liquid Analyzer and Service Market Report| How has COVID-19 affected the market?

Liquid analyzers comprise instruments or analytical products that find use in the determination of chemical composition of the substances.

December 1, 2021
·
4 min read
Policy

Helixmith Announces 50% Enrollment in its Clinical Trial for COVID-19, involving TADIOS

Helixmith Co., Ltd. has announced that 50 subjects have been enrolled in its double-blind placebo controlled COVID-19 clinical trial involving 100 subjects.

December 1, 2021
·
2 min read
Pharm Country

Cresilon Announces FDA 510(k) Submission For Human Use Hemostatic Gel Technology

Cresilon, Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced today it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (“FDA”) for its proprietary hemostatic gel technology.

December 1, 2021
·
1 min read